A biomarker screening pathway that integrates C-peptide and islet autoantibodies may help identify diabetes patients who have monogenic forms of the disease, including maturity-onset diabetes of the young, according to a study in Diabetes Care. UK researchers found that the pathway had a positive predictive value of 20%, "suggesting a 1-in-5 pickup rate for monogenic diabetes, a 5.6-fold increase in probability over the background prevalence alone."
Biomarker-based screening could ID monogenic diabetes, study finds
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.